Coulangeon L M, Sole M, Menerath J M, Sole P
Service d'Ophtalmologie, CHRU, Hôpital Saint-Jacques, Clermont-Ferrand.
Ophtalmologie. 1990 Mar-Apr;4(2):156-61.
A randomized double-blind study of aqueous humor flow and intraocular pressure measurements before and four hours after instillation of placebo and beta-blocker eyedrops, was carried out in 40 hypertensive patients. The treated and non-treated patients either did or didn't show an optic disc excavation and a visual field defect. Hypertensive patients with a previous tension treatment will stop therapy on a 3-week period up to an increase of their own ocular tension value greater than or equal to 3 mmHg. The intraocular pressure statistically decreased of 20.8% four hours after topical placebo, the aqueous humor flow remaining unchanged. In this study, timolol eyedrops induced a greater decrease of the aqueous humor flow (39%), followed equally by betaxolol (23.8%) and carteolol (20.42%). Timolol and betaxolol eyedrops equally induced a significant decrease of the intraocular pressure. There was no effect of carteolol on the intraocular pressure. The outflow facility was independent of the instilled beta-blocker eyedrop.
对40名高血压患者进行了一项随机双盲研究,测量了在滴入安慰剂和β受体阻滞剂眼药水之前以及之后4小时的房水流量和眼压。接受治疗和未接受治疗的患者均有或没有视盘凹陷和视野缺损。之前接受过眼压治疗的高血压患者将在3周内停止治疗,直至其自身眼压值升高大于或等于3 mmHg。局部使用安慰剂4小时后,眼压统计学上降低了20.8%,房水流量保持不变。在这项研究中,噻吗洛尔眼药水使房水流量降低得更多(39%),其次是倍他洛尔(23.8%)和卡替洛尔(20.42%)。噻吗洛尔和倍他洛尔眼药水均使眼压显著降低。卡替洛尔对眼压没有影响。房水流畅系数与所滴入的β受体阻滞剂眼药水无关。